Duke to help Google define what a healthy human looks like [zz]# Biology - 生物学
M*P
1 楼
http://www.bizjournals.com/triangle/news/2014/07/28/duke-to-hel
Tech giant Google will continue its foray into health care and has turned to
Duke University for help.
Google (Nasdaq: GOOG) will look to define health, or establish a basic
understanding of a healthy physiology, in what the Wall Street Journal
called“what may be its most ambitious and difficult science project ever.”
Basically, Google will collect data from healthy volunteers and try to
determine what a healthy person looks like. The study, led by Dr. Andrew
Conrad of Google[x], will begin with a small sample of 175 volunteers,
though Google executives hope to expand that number to thousands.
"The biochemical fingerprint of a healthy individual would be a hugely
important contribution to medical science, and it's possible that this study
could bring that within reach," said Rob Califf, vice chancellor for
clinical and translational research at Duke, and director of the Duke
Translational Medicine Institute. "This is worth striving for, because it
could speed the pace of clinical research for decades to come and enable the
development of new tests and techniques for detecting and preventing
disease."
Tech giant Google will continue its foray into health care and has turned to
Duke University for help.
Google (Nasdaq: GOOG) will look to define health, or establish a basic
understanding of a healthy physiology, in what the Wall Street Journal
called“what may be its most ambitious and difficult science project ever.”
Basically, Google will collect data from healthy volunteers and try to
determine what a healthy person looks like. The study, led by Dr. Andrew
Conrad of Google[x], will begin with a small sample of 175 volunteers,
though Google executives hope to expand that number to thousands.
"The biochemical fingerprint of a healthy individual would be a hugely
important contribution to medical science, and it's possible that this study
could bring that within reach," said Rob Califf, vice chancellor for
clinical and translational research at Duke, and director of the Duke
Translational Medicine Institute. "This is worth striving for, because it
could speed the pace of clinical research for decades to come and enable the
development of new tests and techniques for detecting and preventing
disease."